Experts from the Urea Cycle Disorders Consortium and the National Urea Cycle Disorders Foundation share what they're learning from the “Longitudinal Study of Urea Cycle Disorders.”
New research finds that the nitric oxide deficiencies common in arginosuccinate lyase deficiency (ASLD) create problems with the blood brain barrier, which is essential to maintaining brain health.
New research explores faster and more accurate diagnosis of urea cycle disorders (UCD), variants of uncertain significance, life with a UCD, and more.
Washington, D.C. – Following unanimous support in the Texas House of Representatives and a 30-1 vote in the Senate, Texas Governor Abbott affirmed the state's status as a leader in newborn screening by signing House Bill 2478 into law.
Five months after his death, Robbie Roper's family reveals that his tragic passing was caused by an undiagnosed urea cycle disorder. Robbie received corticosteroids - a known trigger for hyperammonemia - during shoulder surgery, leading to fatal hyperammonemia.
NUCDF and the Rare Diseases Clinical Research Network Urea Cycle Disorders Consortium (UCDC) partner to advance research. Read more about the partnership and current research studies.
NUCDF and the Rare Diseases Clinical Research Network Urea Cycle Disorders Consortium (UCDC)co-host the 5th International Scientific Symposium on Urea Cycle Disorders, "Mapping Progress: Current Concepts and New Insights in Urea Cycle Disorders," on September 22-24, 2021. Read more.
UCD experts, Brendan Lee M.D. Ph.D., Sandesh Nagamani M.D., and Andrea Gropman M.D., provide general guidance about COVID-19 vaccines in individuals with UCD and answer questions submitted by our UCD community. Presented in partnership by NUCDF and the NIH Rare Diseases Clinical Research Network Urea Cycle Disorders Consortium (UCDC).
Dr. Maria Elena Bottazzi, internationally-recognized vaccinologist, provides information and answers questions from our UCD community about the development and types of current vaccines, safety and effectiveness. Presented in partnership by NUCDF and the NIH Rare Diseases Clinical Research Network Urea Cycle Disorders Consortium (UCDC).
